Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Haemonetics Corp

HAE ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Mid Cap Analyst: BUY

Last Close

$90.80

▲ +0.46%

Market Cap $4.13B · Vol 143.41K

Key Metrics

P/E Ratio

44.29

FWD: 16.63

Market Cap

$4.13B

Mid Cap

Div Yield

N/A

EPS Growth

+6.80%

YoY

RSI (14)

73.83

Momentum

Beta

0.53

vs Market

52W High

$92.12

1.43% below

52W Low

$47.39

91.60% above

Volume

143.41K

Avg 189.45K

P/B

3.07

Price-to-book

ROE

29.03%

Return on equity

Free Float

98.65%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Haemonetics Corp (HAE) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HAE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.37%

+22.03%

+58.96%

+57.20%

YTD

+13.29%

+73.51%

-2.19%

+48.51%

Financials & Valuation

TTM · Annual

Total Revenue	$1.33B
Net Income	$97.31M
Revenue Growth (YoY)	+5.60%
Gross Margin	55.70%
Operating Margin	21.64%
Net Profit Margin	7.29%
ROE	29.03%
ROA · ROIC	5.28% · 4.79%

P/E Ratio	44.29
Forward P/E (FY1)	16.63
PEG Ratio	-0.70
P/S	1.92
P/B	3.07
P/FCF	12.27
EPS Growth	+6.80%
Outstanding Shares	45.50M

Technical Indicators

50-Day SMA	$78.92
200-Day SMA	$69.48
RSI (14)	73.83
Beta	0.53
52-Week High	$92.12
52-Week Low	$47.39

Volume Today	143.41K
Avg Daily Volume (30D)	189.45K
Relative Volume	0.76x
Volatility (10D)	33.27
Volatility (30D)	28.73
Free Float	98.65%

Analyst Consensus

BUY

Current Price $90.80

Mean Target $98.11

52W Low$47.39 52W High$92.12

Current

Target

$47.39 $92.12

Current Analyst target

+8.05% upside potential · 11 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S6QB64

ISINUS4050241003

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.